Nearly two years after the FDA issued its last public health notification regarding the risks associated with transvaginal mesh, we continue to hear from alleged victims of vaginal mesh complications on a regular basis.
New York, NY (PRWEB) June 21, 2013
Vaginal mesh lawsuit filings involving Ethicon Inc.’s Gynecare pelvic mesh products continue to mount in a consolidated litigation underway in New Jersey’s Atlantic County Superior Court, Bernstein Liebhard LLP reports. According to the most recent Case List issued by the Court, 3,017 claims have been filed in the New Jersey Ethicon litigation on behalf of alleged victims of vaginal mesh complications. Firm partner, Jeffrey S. Grand, is serving as Co-Liaison Counsel for this litigation. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10).
“It is not at all surprising that the vaginal mesh lawsuits filed in the New Jersey Ethicon litigation have reached this milestone. Nearly two years after the FDA issued its last public health notification regarding the risks associated with transvaginal mesh, we continue to hear from alleged victims of vaginal mesh complications on a regular basis,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to evaluate transvaginal mesh lawsuits on behalf of women allegedly injured by pelvic mesh products marketed by Ethicon, Inc. and other manufacturers.
Vaginal Mesh Complications
Concerns over complications associated with transvaginal mesh devices have been mounting since October 2008, when the U.S. Food and Drug Administration (FDA) alerted the public that it had received more than 1,000 adverse event reports involving patients who had received the implants to treat pelvic organ prolapse and stress urinary incontinence. In July 2011, the FDA issued a second alert after such reports increased by five-fold, with the regulator now warning that the frequency of complications associated with transvaginal prolapse repair was “not rare.” According to the agency, the most frequently reported vaginal mesh complications include mesh erosion through the vaginal epithelium, pain, urinary problems and infection.*
In March, the Plaintiff in the first Ethicon mesh lawsuit to head to trial in the U.S. was awarded more than $11 million, including $7.76 million in punitive damages, after a jury in New Jersey Superior Court found that patients were not properly warned about the risks associated with the Gynecare Prolift device. Jeffrey S. Grand also served on the Plaintiff’s trial team for this case. (Gross v. Gynecare Inc., Atl-L-6966-10, Superior Court of Atlantic County, New Jersey)
Mr. Grand is also serving as Co-Liaison Counsel for a consolidated litigation underway in Atlantic County Superior Court for lawsuits involving pelvic mesh manufactured by C.R. Bard Inc. (In re: Pelvic Mesh Litigation/Bard, No. L-6339-10), and is a member of the Plaintiffs’ Steering Committees in four federal transvaginal mesh multi-district litigations underway in U.S. District Court, Southern District of West Virginia. These proceedings include: In re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2326); In re: C.R. Bard, Inc., In Re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2325”); In re: C.R. Bard, Inc., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2187”); and In re: Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2327”). The first trial in that litigation, involving a C.R. Bard vaginal mesh lawsuit, is scheduled to begin on July 8, 2013.
Alleged victims of vaginal mesh injuries may be eligible to seek compensation for medical expenses, pain and suffering and other damages. Learn more about how to file a vaginal mesh lawsuit by visiting Bernstein Liebhard's website, or by contacting one of the Firm’s attorneys directly at 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
# # #
Felecia L. Stern, Esq.
Bernstein Liebhard LLP